Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

Peer Review reports

Original Submission
21 Nov 2012	Submitted	Original manuscript
30 Nov 2012	Reviewed	Reviewer Report - Ja Seung Koo
10 Dec 2012	Reviewed	Reviewer Report - John Bartlett
31 Jan 2013	Author responded	Author comments - George Fountzilas
Resubmission - Version 2
31 Jan 2013	Submitted	Manuscript version 2
11 Feb 2013	Reviewed	Reviewer Report - Ja Seung Koo
26 Mar 2013	Reviewed	Reviewer Report - John Bartlett
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
20 Mar 2013	Editorially accepted
28 Mar 2013	Article published	10.1186/1471-2407-13-163

Back to article page